WO1994003104A1 - Assay system - Google Patents

Assay system Download PDF

Info

Publication number
WO1994003104A1
WO1994003104A1 PCT/US1993/006967 US9306967W WO9403104A1 WO 1994003104 A1 WO1994003104 A1 WO 1994003104A1 US 9306967 W US9306967 W US 9306967W WO 9403104 A1 WO9403104 A1 WO 9403104A1
Authority
WO
WIPO (PCT)
Prior art keywords
particles
porous
fluid
ligand
conduit means
Prior art date
Application number
PCT/US1993/006967
Other languages
French (fr)
Inventor
Steve J. Lackie
Original Assignee
Sapidyne, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25450611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1994003104(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sapidyne, Inc. filed Critical Sapidyne, Inc.
Priority to DE69333050T priority Critical patent/DE69333050T2/en
Priority to DK93918363T priority patent/DK0606460T3/en
Priority to CA002120481A priority patent/CA2120481C/en
Priority to AT93918363T priority patent/ATE242996T1/en
Priority to JP50537394A priority patent/JP3534756B2/en
Priority to EP93918363A priority patent/EP0606460B1/en
Publication of WO1994003104A1 publication Critical patent/WO1994003104A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N21/0303Optical path conditioning in cuvettes, e.g. windows; adapted optical elements or systems; path modifying or adjustment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/808Optical sensing apparatus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property

Definitions

  • This invention relates to chemical and biochemical assays, and more particularly to an improved optical apparatus and methods for fluorescent assays.
  • Assays in which aliquots of sample-under-test and one or more reagents are variously reacted in highly specific reactions to form ligand/conjugate complexes such as antigen/antibody or similar complexes which may then be observed in order to assay the sample for a titer of a predetermined moiety from the sample, are well known.
  • an antibody is used to assay for the presence of an antigen for which the antibody is specific, but such assays have been extended to quantitate haptens such as hormones, alkaloids, steroids, antigens, antibodies, nucleic acids, and fragments thereof, and it is in this broad sense that the term "ligand/conjugate" as used herein should be understood.
  • Sensitive immunoassays typically use tracer techniques in which a tagged constituent of the complex is incorporated , for example in the reagent, the non-complexed tagged reagent then being separated from the complexed reagent. The complexed can be thereafter quantitated by observing a signal from the tag.
  • Radioisotopes, fluorescent and chemiluminescent molecules , colorimetric tags , and other markers have been used to label constituents or moieties of the complex, appropriate apparatus being employed to detect and measure the radiation from the label.
  • a basic problem arises because of the typically lengthy time required to bind that component to the substrate.
  • fluorescent assays such as those performed in the usual 96 well microtiter plate, require time in the order of hours for binding of a component to the solid phase to occur notwithstanding such expedients as heating, shaking and the like.
  • Known particle assays include the well-known bead agglutination test including quantitative or semiquantitative slide agglutination and techniques in which the agglutinated beads are separated from non-agglutinated beads by passage through a mechanical filter.
  • Another known particle assay is that described in U.S. Patent No. 4,780,423 in which particles with controlled porosity having ligand immobilized thereon are incubated in suspension and washed. Washing can involve sedimentation and resuspension of the particles. The resulting fluorescence can be read either from the concentrated or the suspended particles.
  • the particles are bound to a membrane or filter through which the sample is then poured.
  • a principal object of the present invention is therefore to provide an improved optical assay system in which the kinetics and sensitivity are improved by increasing the surface area of the solid phase, decreasing diffusion distances, and enhancing the optical coupling among the solid phase to the excitation light source and the coupling of the solid phase to the detector.
  • Another object of the present invention is to provide a novel flow cell that provides the desired enhancement between the sample and a detector.
  • Yet other objects of the present invention are to provide such an assay system that requires small sample volume and is particularly suitable for assay of whole blood; to provide such an assay system in which the ligand/conjugate reaction is confined within a disposable item that is readily insertable and removable from the optical system of the flow cell; and to provide such an assay system in which all of the components of the desired complex other than the sample moiety to be assayed, are preprovided.
  • Other objects of the present invention will in part be obvious and will in part appear hereinafter.
  • a system for assaying a fluid sample typically employing a tag or label intended to emit electromagnetic radiation when excited, the system comprising a flow cell comprising hollow, light-transparent conduit means adapted for fluid flow therethrough, and one or more separate porous masses of light-transparent material disposed in the conduit means, the porosity of the mass of transparent material being selected to permit fluid flow of the sample therethrough, at least a moiety of a respective ligand/conjugate complex e.g. a specific-binding ligand, being immobilized, as by precoating, on the surfaces of each mass.
  • a respective ligand/conjugate complex e.g. a specific-binding ligand
  • the mass comprises a plurality of particles preferably substantially transparent to light, particularly, where the complex formed includes a fluorescent label, transparent to both radiation required to excite fluorescence and the excited fluorescence.
  • the particles are typically beads dimensioned within a specified range of diameters and can be preformed, as by sintering or the like.
  • the mass can be formed by accretion against a fluid-porous barrier means disposed in the conduit means.
  • the barrier means is disposed within the conduit means so as to define at least one wall of a chamber, the porosity of the barrier means being sufficiently smaller than said range so that particles entrained in a fluid flow through the conduit means are trapped by the barrier means and accrete to form the porous mass in the chamber.
  • a preferred embodiment of the present invention includes focussing optical lens mean through which the conduit means forms a hollow, tubular passage extending transversely to the optical axis of and through the focal region of the lens means.
  • the lens means comprises a plurality of lenses and the conduit means extends through-one of those lenses.
  • the lens means must be capable of focussing both the excitation and the emission radiation.
  • the invention accordingly comprises the apparatus possessing the construction, combination of elements and arrangement of parts, and the method comprising the several steps and the relation of one or more of such steps with respect to each of the others, all as exemplified in the following detailed disclosure, and the scope of the application of which will be indicated in the claims.
  • Fig. 1 is a diagrammatic representation, in cross-section, of assay apparatus embodying the principles of the present invention
  • Fig. 2 is a schematic cross-section of one embodiment of the flow cell of the present invention
  • Fig. 3 is a transverse cross-section of the flow cell of Fig. 2
  • Fig. 4 is a schematic cross-section of a variation of the flow cell of Fig. 2
  • Fig. 5 is a schematic cross-section of another variation of the flow cell of the present invention
  • Fig. 1 is a diagrammatic representation, in cross-section, of assay apparatus embodying the principles of the present invention
  • Fig. 2 is a schematic cross-section of one embodiment of the flow cell of the present invention
  • Fig. 3 is a transverse cross-section of the flow cell of Fig. 2
  • Fig. 4 is a schematic cross-section of a variation of the flow cell of Fig. 2
  • Fig. 5 is a schematic cross-section of another variation of the flow cell of the present invention
  • FIG. 6 is a schematic cross-section of a variation of the flow cell of Fig. 5;
  • Fig. 7 is a schematic cross-section of another variation of the flow cell of Fig. 5;
  • Fig. 8 is a schematic cross-section of yet another embodiment of the flow cell of the present invention.
  • exemplary apparatus 20 for assaying a fluid sample and which may typically employ an optical system including light source 22 for providing excitation radiation, light detector 24 for detecting light stimulated by the excitation radiation, beam splitter means such as dichroic or semitransparent mirror 26 and collimator means 28.
  • the embodiment of Figs. 1, 2 and 3 will be described, for ease of exposition, for use particularly in the context of fluorescence immunoassay, but it should be understood is not so limited.
  • the term "light” as used herein will be understood to include wavelengths in the visible spectrum as well as those in the near infra-red and ultraviolet as well.
  • the term “excitation” will be understood to include excitation of fluorescence, polarized or not, as by radiation, excitation of chemiluminescence by chemical agents, emission by reflection of light from chromogens, and the like.
  • the foregoing elements of the optical system are typically disposed in a frame (not shown) in fixed optical "relationship to one another, as described more fully hereinafter.
  • the invention further includes a flow cell 30, shown particularly in enlarged form in Figs.
  • a focussing optical lens means 32 shown as a compound lens system including solid focussing lens 33, typically made of glass, high molecular weight polymer or the like.
  • Lens 33 is characterized by having an elongated hollow channel or fluid-flow conducting conduit 34 therein directed transversely to the optical axis of lens 32 and comprising a tubular passage, typically of circular cross-section, through lens 33. At least a portion of such cylindrical conduit, reaction chamber 36, is disposed at the focal region of lens means 32.
  • fluid containing a ligand that can be excited, per se or through an appropriate tag, into emission such as fluorescence traverses chamber 34 and is appropriately excited into emission there by excitation radiation focussed onto chamber 34 by lens means 32. That fluorescent emission is then directed by lens means to dete ⁇ or 24 where, assuming that the detector for example is electrical, appropriate electrical signals are produced and can be assessed to evaluate the fluorescence.
  • the embodiment shown in Fig. 4 includes mechanical, fluid-porous barrier or screen 38 dimensioned and disposed in conduit 34 adjacent the focal region of lens means 32 so as to arrest transport of particles or beads 40 of predetermined size in a flow stream through the conduit.
  • Such beads are substantially transparent to both the excitation radiation and the excited fluorescence, and to that end are typically formed of polymethylmethacrylate, styrene-divinylbenzene copolymer or the like.
  • Beads 40 are coated with at least a moiety of the antibody/antigen complex, e.g. a specific-binding ligand, for example an antigen and an antibody thereto, disposed at least on a portion of the surface of the bead.
  • the mesh or porosity of screen 38 is selected to allow free flow of sample fluid and its constituents therethrough while arresting flow of the coated beads, and thereby accreting a mass of beads 40 against the screen and in the focal region of the lens means 32.
  • the particle size of the beads is selected to be minimized, provided however that when a mass of beads is accreted against screen 38, the sample constituents may still pass freely through the accretion mass.
  • a bead size that works well with whole blood as a sample is in the range of 50 ⁇ m to 250 ⁇ m, preferably around 98 ⁇ m.
  • Bead size depends to some extent on the nature of the sample (e.g. blood, food, urine, process stream and the like).
  • Mesh size depends upon the range of diameters of the beads to be employed in the system, but typically, for beads of about 98 ⁇ m diameter, a mesh size of about 50 ⁇ m is appropriate.
  • sample fluid As sample fluid is flowed through conduit 34, it must pass through the interstices of the accreted mass of coated beads 40, resulting in a very small diffusion distance over which the assayed moiety must pass to complex with the coating on the beads.
  • This small diffusion distance coupled with the long, tortuous path of the sample through the accreted mass and the high surface to volume ratio of the beads, enables very efficient scavenging of the assayed moiety from the sample.
  • This characteristic of the present invention is significant inasmuch as the diffusion time is reduced by the square of the diffusion distance. It should also be noted that the entire solid phase is contained in the accreted mass, a very small volume (e.g.
  • a quantity of beads 40 are preferably preloaded with an appropriate ligand immobilized onto the bead surfaces by adsorption or other known immobilizing techniques and suspended in a suspending fluid. Where the beads will ordinarily not readily form a stable suspension in the suspending fluid, they may be placed into a vo ⁇ exer (not shown) or similar mixer which maintains the beads in a suspension, typically aqueous, by agitation.
  • a desired portion of the bead suspension is sucked out of the vortexer as by a pump (not shown) and injected into conduit 34 where the flow of the beads is arrested by screen 38, creating an accretion or mass of beads 40 within reaction chamber 36.
  • An aliquot of sample solution being assayed is then flowed through conduit 34 and the mass of beads 40 in reaction chamber 36, effecting the formation of a ligand/conjugate complex on the surface of the beads.
  • the sample solution is first treated with a tagging reagent and allowed to incubate.
  • a tagged, typically fluorescent, component may be either the complement or conjugate to or an analog of the immobilized ligand, depending upon whether a competitive or sandwich assay is to be performed.
  • the tag or label is typically a fluorescent dye such as a fluorescein dye, acridine dye or the like, all as well known in the art. In either case, the resulting ligand/conjugate complex should -include desired dye moieties bound to the complex.
  • Light source 22 is then activated to generate excitation light beam 23 (shown in broken lines) which, in turn, directed to mirror 26 by collimating lens 28 so that the collimated beam is reflected onto lens means 32.
  • the latter focusses the excitation beam to a focal region at which the mass of beads 40 in reaction chamber 36 is located, and the excitation radiation excites the fluorophores on beads 40 into fluorescence. That fluorescence is transmitted through lens 32 and directed through beam splitter mirror 26 to detector 24.
  • the mass of beads 40 can be readily removed from reaction chamber 36 simply by back-flushing through conduit 34.
  • the technique of filling the reaction chamber from a suspension or pool of preloaded beads is clearly amenable to automation, where the components for specific assays, such as the type of preloaded beads, sample solution, tagging reagent and the like, are selectable by appropriate valves controlling the flow of materials from respective storage containers.
  • the present invention also is readily adaptable for more portable systems in which the bead mass and reagents are disposables.
  • conduit 34 is shown in Fig. 3 to be simply a passageway through the focal region of lens means 32 transverse to the optical axis of the lens, in the embodiment shown in Fig.
  • conduit 34 is formed of elongated bore 34A of uniform diameter provided similarly through lens 33 and elongated light-transparent tube 42 having a uniform diameter slightly less than that of bore 34A so that tube 42 may be inserted and removed from the bore. Screen 38 is so disposed within tube 42 that the latter can be positioned within bore 34A adjacent the focal region of the lens.
  • conduit 34 is similarly formed of elongated bore 34A of uniform diameter through lens 33 and elongated light-transparent tube 42A having a uniform diameter slightly less than that of bore 34A so that tube 42 may be inserted and removed from the bore.
  • Screens 38A and 38B are so disposed within tube 42 in spaced-apart relation to one another so as to define reaction chamber 44 within the tube.
  • reaction chamber 44 can be positioned within bore 34A adjacent the focal region of the lens.
  • Included within chamber 44 is a plurality of beads 40 dimensioned within a specified range of diameters, the mesh of screens being sufficiently smaller than the range of bead diameters so that the latter are trapped by the screens in chamber 44 to form a porous mass positionable substantially at the lens focal region.
  • the beads in the embodiment of Fig. 6 are preferably precoated with the desired specific binding ligand before installation in chamber 44. In both the embodiments of Figs.
  • tubes 42 are preferably readily insertable and removable in and from bore 34 or 34A as the case may be, hence may be considered to be “disposables".
  • the "disposable" shown in Fig. 6 lends itself to laboratory preloading and packaging in hermetically sealed containers from convenient distribution and use.
  • the materials forming both lens 32 and tube 42A are selected so that the respe ⁇ ive indices of refra ⁇ ion thereof are substantially matched.
  • a refra ⁇ ive index-matching fluid is preferably disposed around the tube in the interspace between the tube and the interior wall of bore 34A.
  • bead mass 40 of the embodiment of Fig. 6 can be formed by, for example, the same technique used to create the bead mass of Fig. 5, i.e. by flowing a suspension of beads through conduit 42 to accrete against a screen such as 38B, the other screen then being emplaced to capture the bead mass.
  • the porous bead mass may also be formed of a plurality of bead adhered lightly to one another as by sintering or adhesives.
  • the bead mass can be formed by providing a thick layer of beads which may be free-standing, or by coating a porous substrate or forming a sandwich between a pair of porous substrates, with the thick layer of beads, which bead layers include a minor amount of adhesive that will not materially reduce the porosity of the resulting mass .
  • the coating can be precoated with an appropriate specifically rea ⁇ ive ligand and minute cylinder of the coating punched out and inserted into appropriately dimensioned tubes 42.
  • sheets of high- molecular weight polymeric material of the desired porosity are commercially available, and after treatment to immobilize the requisite ligand within the porous structure, can be punched to produce the desired cylinders for insertion into tubes 42.
  • conduit 34 can be formed in part as a shallow elongated channel 34B or hemi-tubular portion of, for example, semicircular cross-se ⁇ ion cut or molded into planar surface 48 of lens 33 which extends perpendicularly to the optical axis of the lens and through the focal region of lens means 32.
  • conduit 34 is formed by another hemi-tubular elongated channel 34C, similarly of semicircular cross- se ⁇ ion, provided in plate 50.
  • the latter is attached to lens 32 adjacent surface 48, typically by hinging 52 such that plate 50 can be rotated to match channels 34C and 34B into coaxial relation to form a 'combined conduit of substantially circular cross-se ⁇ ion.
  • the inner surface of channel 34C is provided with highly refle ⁇ ive coating 54. Since certain changes may be made in the above process and apparatus without departing from the scope of the invention herein involved, it is intended that all matter contained in the above description or shown in the accompanying drawing shall be interpreted in an illustrative and not in a limiting sense.

Abstract

A system (30) for assaying a fluid sample. The system (30) comprising a lens (33) capable of focussing both excitation and fluorescent radiation, a fluid-flow conducting conduit (42) being provided in the lens (33) extending transversely of the optical axis of and through the focal region of the latter. At least one mechanical screen (38A, 38B) is disposed adjacent the focal region in the conduit (42) to arrest passage of beads (40) as a function of bead diameter. The beads (40) are precoated with at least a moiety of a ligand/conjugated complex and preferably transparent to both the excitation and fluorescent radiation.

Description

ASSAY SYSTEM
This invention relates to chemical and biochemical assays, and more particularly to an improved optical apparatus and methods for fluorescent assays. Assays in which aliquots of sample-under-test and one or more reagents are variously reacted in highly specific reactions to form ligand/conjugate complexes such as antigen/antibody or similar complexes which may then be observed in order to assay the sample for a titer of a predetermined moiety from the sample, are well known. Typically, an antibody is used to assay for the presence of an antigen for which the antibody is specific, but such assays have been extended to quantitate haptens such as hormones, alkaloids, steroids, antigens, antibodies, nucleic acids, and fragments thereof, and it is in this broad sense that the term "ligand/conjugate" as used herein should be understood. Sensitive immunoassays typically use tracer techniques in which a tagged constituent of the complex is incorporated , for example in the reagent, the non-complexed tagged reagent then being separated from the complexed reagent. The complexed can be thereafter quantitated by observing a signal from the tag. Radioisotopes, fluorescent and chemiluminescent molecules , colorimetric tags , and other markers have been used to label constituents or moieties of the complex, appropriate apparatus being employed to detect and measure the radiation from the label. In such assays where at least one component of the conjugate complex is initially bound to a solid substrate preparatory to formation of the complex, a basic problem arises because of the typically lengthy time required to bind that component to the substrate. For example, fluorescent assays such as those performed in the usual 96 well microtiter plate, require time in the order of hours for binding of a component to the solid phase to occur notwithstanding such expedients as heating, shaking and the like. It will be appreciated that by increasing the surface area of the solid phase made available to binding or coating with a ligand, the binding delay may be considerably reduced. Consequently, the prior art relating to such solid phase assays (such as microtiter well assays, dipstick assays and the like) also teaches using small particles or beads as the solid phase. Flowing the sample through a packed paniculate bed speeds reactions between the sample ligand being assayed and a conjugate immobilized on the surface of the particles. Several factors probably contribute to this enhanced reactivity: the reduced diffusion distance, the constant stirring of sample due to turbulent flow, and the high density of binding sites in the reaction volume due to the high surface area exposed. Known particle assays include the well-known bead agglutination test including quantitative or semiquantitative slide agglutination and techniques in which the agglutinated beads are separated from non-agglutinated beads by passage through a mechanical filter. Another known particle assay is that described in U.S. Patent No. 4,780,423 in which particles with controlled porosity having ligand immobilized thereon are incubated in suspension and washed. Washing can involve sedimentation and resuspension of the particles. The resulting fluorescence can be read either from the concentrated or the suspended particles. In yet another known assay, the particles are bound to a membrane or filter through which the sample is then poured. This technique, is believed to have been limited to enzyme-colorimetric detection. Where the particles are incubated in a water suspension, the average diffusion distances which the free ligand in the sample must traverse and the time required to bring complex formation to completion tend to be quite large. A principal object of the present invention is therefore to provide an improved optical assay system in which the kinetics and sensitivity are improved by increasing the surface area of the solid phase, decreasing diffusion distances, and enhancing the optical coupling among the solid phase to the excitation light source and the coupling of the solid phase to the detector. Another object of the present invention is to provide a novel flow cell that provides the desired enhancement between the sample and a detector. Yet other objects of the present invention are to provide such an assay system that requires small sample volume and is particularly suitable for assay of whole blood; to provide such an assay system in which the ligand/conjugate reaction is confined within a disposable item that is readily insertable and removable from the optical system of the flow cell; and to provide such an assay system in which all of the components of the desired complex other than the sample moiety to be assayed, are preprovided. Other objects of the present invention will in part be obvious and will in part appear hereinafter. Generally, the foregoing and other objects of the present invention are achieved by a system for assaying a fluid sample, typically employing a tag or label intended to emit electromagnetic radiation when excited, the system comprising a flow cell comprising hollow, light-transparent conduit means adapted for fluid flow therethrough, and one or more separate porous masses of light-transparent material disposed in the conduit means, the porosity of the mass of transparent material being selected to permit fluid flow of the sample therethrough, at least a moiety of a respective ligand/conjugate complex e.g. a specific-binding ligand, being immobilized, as by precoating, on the surfaces of each mass. In one embodiment, the mass comprises a plurality of particles preferably substantially transparent to light, particularly, where the complex formed includes a fluorescent label, transparent to both radiation required to excite fluorescence and the excited fluorescence. The particles are typically beads dimensioned within a specified range of diameters and can be preformed, as by sintering or the like. Alternatively, the mass can be formed by accretion against a fluid-porous barrier means disposed in the conduit means. In the latter case.the barrier means is disposed within the conduit means so as to define at least one wall of a chamber, the porosity of the barrier means being sufficiently smaller than said range so that particles entrained in a fluid flow through the conduit means are trapped by the barrier means and accrete to form the porous mass in the chamber. A preferred embodiment of the present invention includes focussing optical lens mean through which the conduit means forms a hollow, tubular passage extending transversely to the optical axis of and through the focal region of the lens means. Typically, the lens means comprises a plurality of lenses and the conduit means extends through-one of those lenses. Where the system is to be used with a tag or label intended to emit electromagnetic radiation when excited, the lens means must be capable of focussing both the excitation and the emission radiation. The invention accordingly comprises the apparatus possessing the construction, combination of elements and arrangement of parts, and the method comprising the several steps and the relation of one or more of such steps with respect to each of the others, all as exemplified in the following detailed disclosure, and the scope of the application of which will be indicated in the claims. For a fuller understanding of the nature and objects of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which like numerals in the several drawings are employed to denote like parts, and wherein: Fig. 1 is a diagrammatic representation, in cross-section, of assay apparatus embodying the principles of the present invention; Fig. 2 is a schematic cross-section of one embodiment of the flow cell of the present invention; Fig. 3 is a transverse cross-section of the flow cell of Fig. 2; Fig. 4 is a schematic cross-section of a variation of the flow cell of Fig. 2; Fig. 5 is a schematic cross-section of another variation of the flow cell of the present invention; Fig. 6 is a schematic cross-section of a variation of the flow cell of Fig. 5; Fig. 7 is a schematic cross-section of another variation of the flow cell of Fig. 5; and Fig. 8 is a schematic cross-section of yet another embodiment of the flow cell of the present invention. In Fig. 1 there is shown exemplary apparatus 20 for assaying a fluid sample and which may typically employ an optical system including light source 22 for providing excitation radiation, light detector 24 for detecting light stimulated by the excitation radiation, beam splitter means such as dichroic or semitransparent mirror 26 and collimator means 28. The embodiment of Figs. 1, 2 and 3 will be described, for ease of exposition, for use particularly in the context of fluorescence immunoassay, but it should be understood is not so limited. The term "light" as used herein will be understood to include wavelengths in the visible spectrum as well as those in the near infra-red and ultraviolet as well. Similarly, the term "excitation" will be understood to include excitation of fluorescence, polarized or not, as by radiation, excitation of chemiluminescence by chemical agents, emission by reflection of light from chromogens, and the like. The foregoing elements of the optical system are typically disposed in a frame (not shown) in fixed optical "relationship to one another, as described more fully hereinafter. The invention further includes a flow cell 30, shown particularly in enlarged form in Figs. 2 and 3, and in this embodiment, formed from a focussing optical lens means 32 shown as a compound lens system including solid focussing lens 33, typically made of glass, high molecular weight polymer or the like. Lens 33 is characterized by having an elongated hollow channel or fluid-flow conducting conduit 34 therein directed transversely to the optical axis of lens 32 and comprising a tubular passage, typically of circular cross-section, through lens 33. At least a portion of such cylindrical conduit, reaction chamber 36, is disposed at the focal region of lens means 32. Thus, for example assume that fluid containing a ligand that can be excited, per se or through an appropriate tag, into emission such as fluorescence, traverses chamber 34 and is appropriately excited into emission there by excitation radiation focussed onto chamber 34 by lens means 32. That fluorescent emission is then directed by lens means to deteαor 24 where, assuming that the detector for example is electrical, appropriate electrical signals are produced and can be assessed to evaluate the fluorescence. In order to provide a better signal-to-ligand ratio, the embodiment shown in Fig. 4 includes mechanical, fluid-porous barrier or screen 38 dimensioned and disposed in conduit 34 adjacent the focal region of lens means 32 so as to arrest transport of particles or beads 40 of predetermined size in a flow stream through the conduit. Such beads are substantially transparent to both the excitation radiation and the excited fluorescence, and to that end are typically formed of polymethylmethacrylate, styrene-divinylbenzene copolymer or the like. Beads 40 are coated with at least a moiety of the antibody/antigen complex, e.g. a specific-binding ligand, for example an antigen and an antibody thereto, disposed at least on a portion of the surface of the bead. The mesh or porosity of screen 38 is selected to allow free flow of sample fluid and its constituents therethrough while arresting flow of the coated beads, and thereby accreting a mass of beads 40 against the screen and in the focal region of the lens means 32. The particle size of the beads is selected to be minimized, provided however that when a mass of beads is accreted against screen 38, the sample constituents may still pass freely through the accretion mass. Typically, a bead size that works well with whole blood as a sample is in the range of 50 μm to 250 μm, preferably around 98 μm. Bead size, of course, depends to some extent on the nature of the sample (e.g. blood, food, urine, process stream and the like). Mesh size, of course, depends upon the range of diameters of the beads to be employed in the system, but typically, for beads of about 98 μm diameter, a mesh size of about 50 μm is appropriate. Thus, as sample fluid is flowed through conduit 34, it must pass through the interstices of the accreted mass of coated beads 40, resulting in a very small diffusion distance over which the assayed moiety must pass to complex with the coating on the beads. This small diffusion distance, coupled with the long, tortuous path of the sample through the accreted mass and the high surface to volume ratio of the beads, enables very efficient scavenging of the assayed moiety from the sample. This characteristic of the present invention is significant inasmuch as the diffusion time is reduced by the square of the diffusion distance. It should also be noted that the entire solid phase is contained in the accreted mass, a very small volume (e.g. about 0.02cm3 for a typical conduit of 0.18 cm diameter), and is "immersed" in lens 32 thus providing a high numerical aperture, optical coupling between the excitation and detection systems. Because the fluorescent signal is increased by the fourth power of the numerical aperture, high numerical aperture optical coupling is very important. In operation of the invention shown in Fig. 4, a quantity of beads 40 are preferably preloaded with an appropriate ligand immobilized onto the bead surfaces by adsorption or other known immobilizing techniques and suspended in a suspending fluid. Where the beads will ordinarily not readily form a stable suspension in the suspending fluid, they may be placed into a voπexer (not shown) or similar mixer which maintains the beads in a suspension, typically aqueous, by agitation. A desired portion of the bead suspension is sucked out of the vortexer as by a pump (not shown) and injected into conduit 34 where the flow of the beads is arrested by screen 38, creating an accretion or mass of beads 40 within reaction chamber 36. An aliquot of sample solution being assayed is then flowed through conduit 34 and the mass of beads 40 in reaction chamber 36, effecting the formation of a ligand/conjugate complex on the surface of the beads. As is well known, for competitive assays, prior to flowing the sample solution through the flow cell, typically the sample solution is first treated with a tagging reagent and allowed to incubate. Where the assay is a sandwich assay, the sample solution is passed through the flow cell, then tagged antibody is passed through the cell, and the bead mass is subjected to a wash step. As is well known in the an, a tagged, typically fluorescent, component may be either the complement or conjugate to or an analog of the immobilized ligand, depending upon whether a competitive or sandwich assay is to be performed. The tag or label is typically a fluorescent dye such as a fluorescein dye, acridine dye or the like, all as well known in the art. In either case, the resulting ligand/conjugate complex should -include desired dye moieties bound to the complex. Flowing a wash buffer through the bead mass then washes out any unreacted materials and particularly any free dye components, leaving only those dyed moieties as are immobilized on the beads. Light source 22 is then activated to generate excitation light beam 23 (shown in broken lines) which, in turn, directed to mirror 26 by collimating lens 28 so that the collimated beam is reflected onto lens means 32. The latter focusses the excitation beam to a focal region at which the mass of beads 40 in reaction chamber 36 is located, and the excitation radiation excites the fluorophores on beads 40 into fluorescence. That fluorescence is transmitted through lens 32 and directed through beam splitter mirror 26 to detector 24. After measurements are made, the mass of beads 40 can be readily removed from reaction chamber 36 simply by back-flushing through conduit 34. As thus described , the technique of filling the reaction chamber from a suspension or pool of preloaded beads is clearly amenable to automation, where the components for specific assays, such as the type of preloaded beads, sample solution, tagging reagent and the like, are selectable by appropriate valves controlling the flow of materials from respective storage containers. However, the present invention also is readily adaptable for more portable systems in which the bead mass and reagents are disposables. For example, while conduit 34 is shown in Fig. 3 to be simply a passageway through the focal region of lens means 32 transverse to the optical axis of the lens, in the embodiment shown in Fig. 5, conduit 34 is formed of elongated bore 34A of uniform diameter provided similarly through lens 33 and elongated light-transparent tube 42 having a uniform diameter slightly less than that of bore 34A so that tube 42 may be inserted and removed from the bore. Screen 38 is so disposed within tube 42 that the latter can be positioned within bore 34A adjacent the focal region of the lens. In yet another embodiment of the flow cell of the present invention, as shown in Fig. 6, conduit 34 is similarly formed of elongated bore 34A of uniform diameter through lens 33 and elongated light-transparent tube 42A having a uniform diameter slightly less than that of bore 34A so that tube 42 may be inserted and removed from the bore. Screens 38A and 38B are so disposed within tube 42 in spaced-apart relation to one another so as to define reaction chamber 44 within the tube. As in the embodiment of Fig. 5, reaction chamber 44 can be positioned within bore 34A adjacent the focal region of the lens. Included within chamber 44 is a plurality of beads 40 dimensioned within a specified range of diameters, the mesh of screens being sufficiently smaller than the range of bead diameters so that the latter are trapped by the screens in chamber 44 to form a porous mass positionable substantially at the lens focal region. The beads in the embodiment of Fig. 6 are preferably precoated with the desired specific binding ligand before installation in chamber 44. In both the embodiments of Figs. 5 and 6, it will be appreciated that tubes 42 are preferably readily insertable and removable in and from bore 34 or 34A as the case may be, hence may be considered to be "disposables". Particularly, the "disposable" shown in Fig. 6 lends itself to laboratory preloading and packaging in hermetically sealed containers from convenient distribution and use. In both the embodiments of Figs. 5 and 6, the materials forming both lens 32 and tube 42A are selected so that the respeαive indices of refraαion thereof are substantially matched. In order to provide the optimum optical coupling between tube 42A and lens 32, a refraαive index-matching fluid is preferably disposed around the tube in the interspace between the tube and the interior wall of bore 34A. It should be understood that bead mass 40 of the embodiment of Fig. 6 can be formed by, for example, the same technique used to create the bead mass of Fig. 5, i.e. by flowing a suspension of beads through conduit 42 to accrete against a screen such as 38B, the other screen then being emplaced to capture the bead mass. Alternatively, the porous bead mass may also be formed of a plurality of bead adhered lightly to one another as by sintering or adhesives. For example, the bead mass can be formed by providing a thick layer of beads which may be free-standing, or by coating a porous substrate or forming a sandwich between a pair of porous substrates, with the thick layer of beads, which bead layers include a minor amount of adhesive that will not materially reduce the porosity of the resulting mass . After curing, the coating can be precoated with an appropriate specifically reaαive ligand and minute cylinder of the coating punched out and inserted into appropriately dimensioned tubes 42. Alternatively, sheets of high- molecular weight polymeric material of the desired porosity are commercially available, and after treatment to immobilize the requisite ligand within the porous structure, can be punched to produce the desired cylinders for insertion into tubes 42. Thus, one may provide a plurality of bead masses, each coated with a different ligand. The resulting plurality of bead masses can be emplaced in a single tube 42, as shown in Fig. 7, so that one may assay a sample flowing through the tube for several different ligands separately but substantially simultaneously. As shown in Fig. 8, conduit 34 can be formed in part as a shallow elongated channel 34B or hemi-tubular portion of, for example, semicircular cross-seαion cut or molded into planar surface 48 of lens 33 which extends perpendicularly to the optical axis of the lens and through the focal region of lens means 32. The remainder of conduit 34 is formed by another hemi-tubular elongated channel 34C, similarly of semicircular cross- seαion, provided in plate 50. The latter is attached to lens 32 adjacent surface 48, typically by hinging 52 such that plate 50 can be rotated to match channels 34C and 34B into coaxial relation to form a 'combined conduit of substantially circular cross-seαion. In the preferred embodiment, the inner surface of channel 34C is provided with highly refleαive coating 54. Since certain changes may be made in the above process and apparatus without departing from the scope of the invention herein involved, it is intended that all matter contained in the above description or shown in the accompanying drawing shall be interpreted in an illustrative and not in a limiting sense.

Claims

What is claimed is: 1. A flow cell for use in apparatus for assaying a fluid sample, said apparatus comprising, in combination: hollow, light-transparent conduit means adapted for fluid flow therethrough; and and a porous mass of light-transparent material disposed in said conduit means, the porosity of said mass of transparent material being seleαed to permit fluid flow of said sample therethrough, said mass having immobilized on the surfaces thereof, at least a moiety of a ligand/conjugate complex.
2. A flow cell as defined in claim 1 including fluid-porous barrier means disposed within said conduit means so as to define at least one wall of a chamber in said conduit means; and wherein said porous mass comprises a plurality of particles dimensioned within a specified range of diameters, the porosity of said barrier means being sufficiently smaller than said range so that said particles are trapped by said barrier means in said chamber to form said porous mass.
3. Apparatus as defined in claim 2 wherein said barrier means comprises at least a pair of screens spaced apart from one another so as to define a reaαion chamber within said conduit means, the mesh of said screens being sufficiently smaller than said range of diamerers so that said particles are trapped by said screens in said chamber to form said porous mass, said particles having immobilized on the surfaces thereof, at least a respeαive moiety of said ligand/conjugate complex.
4. Apparatus as defined in claim 2 wherein said barrier means comprises a plurality of pairs of screens, the screen of each said pair being spaced apart from one another so as to define a respective reaαion chamber within said conduit means; each said chamber including a plurality of particles dimensioned within a specified range of diameters, the mesh of said screens being sufficiently smaller than said range of diameters so that said particles are trapped by said screens in each said chamber to form a respeαive porous mass, the particles of each said mass having immobilized on the surfaces thereof, at least a respective moiety of a respeαive ligand/conjugate complex.
5. A flow cell for use in apparatus for assaying a fluid sample, said apparatus comprising, in combination: focussing optical lens means; a hollow, cylindrical passage through said lens means adapted for fluid flow therethrough and extending transversely to the optical axis of said lens means through the focal region of said lens means.
6. Apparatus as defined in claim 5 wherein said lens means comprises a plurality of lenses and said passage comprises conduit means extending through one of said lenses.
7. Apparatus as defined in claim 6 including a porous mass of light-transparent material disposed in said conduit means, the porosity of said mass of transparent material being seleαed to permit flow of said fluid sample therethrough, said mass having immobilized on the surfaces thereof, at least a moiety of a ligand/conjugate complex.
8. A flow cell as defined in claim 5 including mechanical, fluid-porous barrier means dimensioned and disposed adjacent said focal region so as to block flow of particulates of predetermined size through said conduit means.
9. Apparatus as defined in claim 6 including a first elongated hemi-tubular channel in said one of said lenses and a second elongated hemi-tubular channel, said channels being mateable with one another to define said conduit means.
10. Apparatus as defined in claim 9 wherein said second hemi-tubular channel has a light refleαive surface on the concave portion thereof.
11. Apparatus as defined in claim 9 wherein said one elongated edge of said first channel is hingedly conneαed to an elongated edge of said second channel.
12. Apparatus as defined in claim 8 wherein said hollow conduit means comprises a light-transparent tube positioned within said cylindrical passage, said barrier means being disposed in said tube.
13. Apparatus as defined in claim 12 wherein said barrier means comprise a pair of screens spaced apart from one another so as to define a reaαion chamber within said tube; and including a plurality of particles dimensioned within a specified range of diameters, the mesh of said screens being sufficiently smaller than said range so that said particles are trapped by said screens in said chamber to form a porous mass positionable substantially at said focal region.
14. Apparatus as defined in claim 12 wherein the indices of refraαion of said lens means and said tube are substantially matched.
15. Apparatus as defined in claim 14 including an refraαive index-matching fluid disposed around said tube and in the interspace between said tube and said passage.
16. Apparatus as defined in claim 7 wherein one portion of said passage is formed as an elongated hemi-tubular first channel in said lens means and the remaining portion of said passage is formed as an elongated hemi-tubular second channel, matched to said first channel.
17. Apparatus as defined in claim 16 wherein said second channel has a refleαive surface forming at leϋast a part of the inner surface of said passage.
18. Apparatus as defined in claim 8 including a plurality of particles dimensioned within a specified range of diameters, said fluid-porous means having pores of lesser diameter than said range so that said particles are accreted in said conduit means against said barrier means to form a porous mass disposed substantially at said focal region.
19. Apparatus as defined in claim 18 wherein said particles are substantially transparent to light.
20. Apparatus as defined in claim 19 wherein said particles are coated on at least on a portion of the surface thereof with at least a moiety of a ligand/conjugate complex.
21. Apparatus for assaying a fluid sample using a tag capable of emitting eleαromagnetic radiation when excited, said apparatus comprising: lens means capable of focussing said radiation and having conduit means therein extending transversely of the optical axis of said lens means through the focal region of said lens means, said conduit means being adapted for fluid flow therethrough ; fluid-porous barrier means disposed adjacent said focal region in said conduit means for limiting the passage of particles through said porous means as a funαion of particle size.
22. Apparatus as defined in claim 21 including means for exciting emission of said eleαromagnetic radiation.
23. Apparatus as defined in claim 22 wherein said means for exciting said emission comprise a source of excitation radiation and means for direαing said excitation radiation at said conduit means at said focal region.
24. Apparatus as defined in claim 23 wherein said emission is fluorescent radiation.
25. Apparatus as defined in claim 23 including a plurality of particles dimensioned within a specified range of diameters, said fluid-porous means having pores of lesser diameter than said range so that said particles are accreted in said conduit means against said porous barrier to form a porous mass disposed substantially at said focal region.
26. Apparatus as defined in claim 25 wherein said particles are substantially transparent to both said excitation radiation and said fluorescent radiation, and are coated with immobilized specific binding ligand.
27. Apparatus as defined in claim 26 wherein said ligand has formed a complex in a ligand/conjugate reaαion, said complex being tagged with molecules capable of fluorescing when excited by appropriate excitation radiation.
28. Method of assaying a fluid sample by deteαion of radiation emitted from a ligand/conjugate complex, said method comprising the steps of: providing a plurality of particles dimensioned within a specified range of diameters; flowing a suspension of said particles through conduit means extending transversely of the optic axis of lens means through the focal region of the latter; arresting the flow of said particles through said conduit by porous means having pores of lesser diameter than said range, so that said particles accrete substantially at said focal region; treating said accretion of particles, including flowing at least said fluid sample therethrough, so as to create said ligand/conjugate complex on the surfaces of said particles; stimulating said complex so that charaαeristic radiation arises therefrom; and deteαing emission of said charaαeristic radiation transmitted by said lens means .
29. Method of assaying as defined in claim 28 wherein said treating includes coating said particles at least on a portion of the surface thereof with at least a moiety of said complex; tagging said complex with a fluorescent label; and flowing through said conduit means and said accretion of said particles a wash fluid to separate unreaαed conjugate and fluorescent label from the tagged complex.
30. Method of assaying as defined in claim 28 wherein said stimulating includes direαing excitation radiation onto said tagged complex; and said charaαeristic radiation comprises fluorescence arising from the excited tagged complex and passing through said lens means.
PCT/US1993/006967 1992-08-03 1993-07-23 Assay system WO1994003104A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE69333050T DE69333050T2 (en) 1992-08-03 1993-07-23 ARRANGEMENT FOR SAMPLING
DK93918363T DK0606460T3 (en) 1992-08-03 1993-07-23 Sample Determination System
CA002120481A CA2120481C (en) 1992-08-03 1993-07-23 Assay system
AT93918363T ATE242996T1 (en) 1992-08-03 1993-07-23 ARRANGEMENT FOR SAMPLE DETERMINATION
JP50537394A JP3534756B2 (en) 1992-08-03 1993-07-23 Test system
EP93918363A EP0606460B1 (en) 1992-08-03 1993-07-23 Assay system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/924,720 1992-08-03
US07/924,720 US5372783A (en) 1992-08-03 1992-08-03 Assay system

Publications (1)

Publication Number Publication Date
WO1994003104A1 true WO1994003104A1 (en) 1994-02-17

Family

ID=25450611

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/006967 WO1994003104A1 (en) 1992-08-03 1993-07-23 Assay system

Country Status (8)

Country Link
US (3) US5372783A (en)
EP (1) EP0606460B1 (en)
JP (4) JP3534756B2 (en)
AT (1) ATE242996T1 (en)
CA (2) CA2518356C (en)
DE (1) DE69333050T2 (en)
DK (1) DK0606460T3 (en)
WO (1) WO1994003104A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664114B1 (en) 1992-08-03 2003-12-16 Sapidyne Instruments, Inc. Solid phase assay for detection of ligands
US7754498B2 (en) 1997-10-06 2010-07-13 Trustees Of Tufts College Self-encoding sensor with microspheres
USRE43097E1 (en) 1994-10-13 2012-01-10 Illumina, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US8173441B2 (en) 2000-09-27 2012-05-08 Universiteit Leiden Method for applying NMR for ligand discovery or as a drug screening tool
US9273354B2 (en) 1997-05-23 2016-03-01 Illumina, Inc. System and apparatus for sequential processing of analytes

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372783A (en) * 1992-08-03 1994-12-13 Sapidyne, Inc. Assay system
AU6357394A (en) * 1993-03-04 1994-09-26 Sapidyne, Inc. Assay flow apparatus and method
US5660798A (en) * 1993-04-20 1997-08-26 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5485270A (en) * 1994-07-25 1996-01-16 General Signal Corporation Dynamic light scattering microvolume cell assembly for continuous flow dialysis
WO1996008703A1 (en) * 1994-09-14 1996-03-21 X-Rite, Incorporated Scanning colorimeter
EP0781404A4 (en) * 1994-09-14 1999-07-21 X Rite Inc Compact spectrophotometer
EP0879417A1 (en) 1996-02-09 1998-11-25 Kalibrant Limited Assay apparatus
GB2324603B (en) * 1996-02-09 1999-08-04 Kalibrant Limited Assay apparatus
US5670375A (en) * 1996-02-21 1997-09-23 Biomerieux Vitek, Inc. Sample card transport method for biological sample testing machine
US6025189A (en) * 1997-05-14 2000-02-15 3M Innovative Properties Company Apparatus for reading a plurality of biological indicators
GB9717020D0 (en) * 1997-08-12 1997-10-15 Kalibrant Limited An assay apparatus with multiple detectors
US7115884B1 (en) * 1997-10-06 2006-10-03 Trustees Of Tufts College Self-encoding fiber optic sensor
US6100541A (en) 1998-02-24 2000-08-08 Caliper Technologies Corporation Microfluidic devices and systems incorporating integrated optical elements
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
US6290912B1 (en) * 1998-07-14 2001-09-18 Bayer Corporation Read head for luminometer
US6623971B2 (en) * 1999-01-11 2003-09-23 Bayer Corporation Method and apparatus for conducting a stat immunoassay analysis in a capsule chemistry analysis system
JP2001004628A (en) * 1999-06-18 2001-01-12 Kanagawa Acad Of Sci & Technol Immunoassay and its method
US6867859B1 (en) 1999-08-03 2005-03-15 Lightwind Corporation Inductively coupled plasma spectrometer for process diagnostics and control
US6239871B1 (en) * 1999-08-24 2001-05-29 Waters Investments Limited Laser induced fluorescence capillary interface
US20020004246A1 (en) * 2000-02-07 2002-01-10 Daniels Robert H. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
US6690467B1 (en) * 2000-05-05 2004-02-10 Pe Corporation Optical system and method for optically analyzing light from a sample
ATE303863T1 (en) * 2000-10-17 2005-09-15 Febit Ag METHOD AND DEVICE FOR INTEGRATED SYNTHESIS AND ANALYTE DETERMINATION ON A SUPPORT
US6538734B2 (en) * 2000-11-29 2003-03-25 Lightwind Corporation Method and device utilizing real-time gas sampling
US7691645B2 (en) * 2001-01-09 2010-04-06 Agilent Technologies, Inc. Immunosubtraction method
EP1373856B1 (en) 2001-03-02 2018-11-14 Waters Technologies Corporation Fluorescence detector geometry
US6519033B1 (en) 2001-11-19 2003-02-11 Point Source Technologies, Llc Identification of particles in fluid
US6774995B2 (en) 2001-08-03 2004-08-10 Pointsource Technologies, Llc Identification of particles in fluid
US6573992B1 (en) 2001-11-13 2003-06-03 Pointsource Technologies, Llc Plano convex fluid carrier for scattering correction
US6590652B2 (en) 2001-11-02 2003-07-08 Pointsource Technologies, Inc. Flow through light scattering device
US6628386B2 (en) 2001-12-12 2003-09-30 Pointsource Technologies, Llc Particle detection beam
US6930769B1 (en) 2002-03-21 2005-08-16 Pointsource Technologies, Llc Optical sensor module tester
US7057724B1 (en) 2002-03-21 2006-06-06 Institute Of Critical Care Medicine Particulate info to field units
US6972424B1 (en) 2002-04-16 2005-12-06 Pointsource Technologies, Llc High detection rate particle identifier
JP2004069397A (en) * 2002-08-02 2004-03-04 Nec Corp Analysis chip and analytical apparatus
US7901630B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Diffraction grating-based encoded microparticle assay stick
US7441703B2 (en) 2002-08-20 2008-10-28 Illumina, Inc. Optical reader for diffraction grating-based encoded optical identification elements
US7900836B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Optical reader system for substrates having an optically readable code
US7923260B2 (en) 2002-08-20 2011-04-12 Illumina, Inc. Method of reading encoded particles
US7508608B2 (en) 2004-11-17 2009-03-24 Illumina, Inc. Lithographically fabricated holographic optical identification element
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
US7872804B2 (en) 2002-08-20 2011-01-18 Illumina, Inc. Encoded particle having a grating with variations in the refractive index
WO2004025563A1 (en) 2002-09-12 2004-03-25 Cyvera Corporation Diffraction grating-based encoded micro-particles for multiplexed experiments
US20100255603A9 (en) 2002-09-12 2010-10-07 Putnam Martin A Method and apparatus for aligning microbeads in order to interrogate the same
WO2004024328A1 (en) 2002-09-12 2004-03-25 Cyvera Corporation Method and apparatus for aligning elongated microbeads in order to interrogate the same
US7092160B2 (en) 2002-09-12 2006-08-15 Illumina, Inc. Method of manufacturing of diffraction grating-based optical identification element
SE0203548D0 (en) * 2002-12-02 2002-12-02 Biacore Ab Method of determining site-specificity and kit therefor
US20040175821A1 (en) * 2003-03-07 2004-09-09 Ehman Michael F. Integrated photodetector for heavy metals and biological activity analysis
US6819421B1 (en) 2003-04-11 2004-11-16 Point Source Technologies, Llc Detection of new species of particles
KR101531400B1 (en) 2003-06-27 2015-06-26 암젠 프레몬트 인코포레이티드 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
US7433123B2 (en) 2004-02-19 2008-10-07 Illumina, Inc. Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
JP4579593B2 (en) * 2004-03-05 2010-11-10 キヤノン株式会社 Target substance recognition element, detection method and apparatus
US7177023B2 (en) * 2004-03-19 2007-02-13 Applera Corporation Fluorescent light detection
WO2006020363A2 (en) 2004-07-21 2006-02-23 Illumina, Inc. Method and apparatus for drug product tracking using encoded optical identification elements
EP1776585B1 (en) * 2004-07-23 2010-07-07 Biosystem Development, LLC Immunoassay assembly and methods of use
EP1901067A3 (en) * 2004-08-03 2009-05-13 On-Chip Cellomics Consortium Cellomics system
US7604173B2 (en) 2004-11-16 2009-10-20 Illumina, Inc. Holographically encoded elements for microarray and other tagging labeling applications, and method and apparatus for making and reading the same
WO2006055736A1 (en) 2004-11-16 2006-05-26 Illumina, Inc. And methods and apparatus for reading coded microbeads
WO2006055735A2 (en) 2004-11-16 2006-05-26 Illumina, Inc Scanner having spatial light modulator
US20080245971A1 (en) * 2005-10-03 2008-10-09 Koninklijke Philips Electronics, N.V. Biosensors with Improved Sensitivity
US7623624B2 (en) 2005-11-22 2009-11-24 Illumina, Inc. Method and apparatus for labeling using optical identification elements characterized by X-ray diffraction
JP4782593B2 (en) * 2006-03-13 2011-09-28 株式会社日立製作所 Photodetector
US7830575B2 (en) 2006-04-10 2010-11-09 Illumina, Inc. Optical scanner with improved scan time
US20080018894A1 (en) * 2006-05-07 2008-01-24 Zu Jianping Lily Optical ball lens light scattering apparatus and method for use thereof
US8012349B2 (en) * 2006-11-20 2011-09-06 Orbital Biosciences, Llc Small volume unitary molded filters and supports for adsorbent beds
DE102007020610A1 (en) * 2007-04-30 2008-11-20 Thomas Dr. Ruckstuhl Container and method for detecting fluorescence
DE102007033124B4 (en) * 2007-07-16 2012-12-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for the optical detection of substances in a liquid or gaseous medium
CN101939632B (en) * 2008-02-07 2013-05-01 三井造船株式会社 Fluorescent light detection device and fluorescent light detection method
US8576396B2 (en) * 2008-11-19 2013-11-05 Postnova Analytics Gmbh Cell construction for light scatter detectors having self-focusing properties
US7957002B2 (en) * 2009-03-13 2011-06-07 The Furukawa Electric Co., Ltd. Method for optical measurement and optical measurement apparatus
WO2011123092A1 (en) * 2010-03-29 2011-10-06 Analogic Corporation Optical detection system and/or method
WO2012059786A1 (en) 2010-11-03 2012-05-10 Reametrix Inc. Measurement system for fluorescent detection, and method therefor
US20140314667A1 (en) 2011-11-16 2014-10-23 Amgen Inc. Methods of treating epidermal growth factor deletion mutant viii related disorders
WO2013136891A1 (en) * 2012-03-12 2013-09-19 オリンパス株式会社 Spectroscopic device, spectroscopic lens and spectroscopic container
DE102016113042A1 (en) * 2016-07-15 2018-01-18 B. Braun Melsungen Ag Flow cell device for measuring fluid parameters
DE102019219949A1 (en) * 2019-12-18 2021-06-24 Robert Bosch Gmbh Substrate

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025142A (en) * 1959-10-30 1962-03-13 Dale D Williams Method and means of detecting ammonia and amine vapor
US3492396A (en) * 1967-03-13 1970-01-27 Becton Dickinson Co Agglutinate separation method and apparatus
US4059685A (en) * 1973-03-19 1977-11-22 Summa Corporation Immobilized immunoadsorbent
US4425438A (en) * 1981-03-13 1984-01-10 Bauman David S Assay method and device
US4652533A (en) * 1983-04-28 1987-03-24 Pandex Laboratories, Inc. Method of solid phase immunoassay incorporating a luminescent label
US4714345A (en) * 1984-06-29 1987-12-22 Bernhard Schrader Sample arrangement for spectrometry, method for the measurement of luminescence and scattering and application of the sample arrangement

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1716321A (en) * 1927-05-26 1929-06-04 Robert D Pearson Lens
US2798718A (en) * 1951-10-26 1957-07-09 William E Gross Canister spring
US3002092A (en) * 1954-09-30 1961-09-26 Donald S Cary Optical system for infrared target tracking apparatus
US2978718A (en) * 1957-08-27 1961-04-11 Service Metal Fabricators Inc Vehicle wheel washing device
US3600063A (en) * 1969-04-28 1971-08-17 Thomas R Bowen Varifocal beam spreader
US4036946A (en) * 1975-10-20 1977-07-19 Marcos Kleinerman Immunofluorometric method for measuring minute quantities of antigens, antibodies and other substances
US4268171A (en) * 1977-07-18 1981-05-19 Beckman Instruments, Inc. Method determining concentration in rate nephelometric immunochemical analysis
US4173392A (en) * 1977-07-20 1979-11-06 American Hospital Supply Corporation Glass fiber light guide and method of making the same
US4348107A (en) * 1980-07-18 1982-09-07 Coulter Electronics, Inc. Orifice inside optical element
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
US4582809A (en) * 1982-06-14 1986-04-15 Myron J. Block Apparatus including optical fiber for fluorescence immunoassay
US4505260A (en) * 1982-09-09 1985-03-19 Metzger Research Corporation Radiant energy device
IT1212960B (en) * 1983-10-25 1989-12-07 Russo Vera Firenze Via D Panch MANUFACTURING METHOD FOR MICRO-LENS TERMINATIONS FOR OPTICAL FIBERS, PARTICULARLY FOR BIOMEDICAL AND / OR SURGICAL USE, AND DEVICE FOR CARRYING OUT THIS METHOD
US4585623A (en) * 1984-02-27 1986-04-29 Allelix Inc. Device for performing quantitative chemical and immunochemical assays
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4963498A (en) * 1985-08-05 1990-10-16 Biotrack Capillary flow device
US4912051A (en) * 1986-08-04 1990-03-27 The United States Of America As Represented By The United States Department Of Energy Permeation absorption sampler with multiple detection
US4775515A (en) * 1986-11-18 1988-10-04 Cottingham Hugh V Agglutinographic slide
US4780423A (en) * 1986-12-09 1988-10-25 Ciba Corning Diagnostics Corp. Heterogeneous fluorescence assays using controlled pore glass particles
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
ATE112181T1 (en) * 1989-06-20 1994-10-15 Claudio Bonini TEST TUBES WITH A LENTRIC SURFACE, PARTICULARLY FOR AUTOMATIC CLINICAL ANALYZES.
US5183740A (en) * 1990-02-23 1993-02-02 The United States Of America As Represented By The Secretary Of The Navy Flow immunosensor method and apparatus
US5372783A (en) * 1992-08-03 1994-12-13 Sapidyne, Inc. Assay system

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025142A (en) * 1959-10-30 1962-03-13 Dale D Williams Method and means of detecting ammonia and amine vapor
US3492396A (en) * 1967-03-13 1970-01-27 Becton Dickinson Co Agglutinate separation method and apparatus
US4059685A (en) * 1973-03-19 1977-11-22 Summa Corporation Immobilized immunoadsorbent
US4425438A (en) * 1981-03-13 1984-01-10 Bauman David S Assay method and device
US4652533A (en) * 1983-04-28 1987-03-24 Pandex Laboratories, Inc. Method of solid phase immunoassay incorporating a luminescent label
US4714345A (en) * 1984-06-29 1987-12-22 Bernhard Schrader Sample arrangement for spectrometry, method for the measurement of luminescence and scattering and application of the sample arrangement

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664114B1 (en) 1992-08-03 2003-12-16 Sapidyne Instruments, Inc. Solid phase assay for detection of ligands
US7091050B2 (en) 1992-08-03 2006-08-15 Sapidyne Instruments Inc. Solid phase assay for detection of ligands
USRE43097E1 (en) 1994-10-13 2012-01-10 Illumina, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US9273354B2 (en) 1997-05-23 2016-03-01 Illumina, Inc. System and apparatus for sequential processing of analytes
US7754498B2 (en) 1997-10-06 2010-07-13 Trustees Of Tufts College Self-encoding sensor with microspheres
US8030094B2 (en) 1997-10-06 2011-10-04 Trustees Of Tufts College Self-encoding sensor with microspheres
US8426217B2 (en) 1997-10-06 2013-04-23 Trustees Of Tufts College Self-encoding sensor with microspheres
US8691591B2 (en) 1997-10-06 2014-04-08 Trustees Of Tufts College Self-encoding sensor with microspheres
US9157113B2 (en) 1997-10-06 2015-10-13 Trustees Of Tufts College, Tufts University Self-encoding sensor with microspheres
US8173441B2 (en) 2000-09-27 2012-05-08 Universiteit Leiden Method for applying NMR for ligand discovery or as a drug screening tool

Also Published As

Publication number Publication date
JP2005321416A (en) 2005-11-17
JP3534756B2 (en) 2004-06-07
ATE242996T1 (en) 2003-07-15
US6120734A (en) 2000-09-19
EP0606460B1 (en) 2003-06-18
JP2006258824A (en) 2006-09-28
US5554340A (en) 1996-09-10
JP4102837B2 (en) 2008-06-18
CA2518356C (en) 2009-11-24
CA2518356A1 (en) 1994-02-17
JPH07500191A (en) 1995-01-05
CA2120481C (en) 2005-12-20
DE69333050T2 (en) 2004-05-27
EP0606460A4 (en) 1994-12-07
CA2120481A1 (en) 1994-02-17
JP2004069716A (en) 2004-03-04
EP0606460A1 (en) 1994-07-20
US5372783A (en) 1994-12-13
DK0606460T3 (en) 2003-10-13
DE69333050D1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
US5372783A (en) Assay system
US4558014A (en) Assay apparatus and methods
US5350697A (en) Scattered light detection apparatus
US4568649A (en) Immediate ligand detection assay
US4680275A (en) Homogeneous fluorescence immunoassay using a light absorbing material
JP2568517B2 (en) Fluorescent immunoassay device and method
EP0154734B1 (en) Immediate ligand detection assay, a test kit and its formation
US5176881A (en) Fiber optic-based regenerable biosensor
US5565365A (en) Assay flow apparatus and method
US4582809A (en) Apparatus including optical fiber for fluorescence immunoassay
EP0103426A2 (en) Immunoassay apparatus and method
US6008057A (en) Immunoassay system
JPS5934154A (en) Determination by means of immunoanalytical element
EP0222341A1 (en) A method for immunoassay and reagents therefor
JP2003507736A (en) Method for measuring substances using the evanescence field method
CA2283251C (en) Device and method for carrying out fluorescence immunoassays
EP0397659A1 (en) Process for detecting biochemical species and apparatus useful therein
EP1084408B1 (en) Homogeneous biospecific assay using a solid phase, two-photon excitation and confocal fluorescence detection
JP2766677B2 (en) Multi-parameter particle analysis
CA2179826C (en) Method of assay
MXPA06005123A (en) Method for extending the dynamic detection range of assay devices
CA2149537A1 (en) Method for preparing calibration curves

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2120481

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993918363

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1993918363

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993918363

Country of ref document: EP